Email not displaying properly? View email in your browser
Vertical-Talk Healthcare   >  Artificial Intelligence
>  Nanomedicine
>  Cancer Treatment
  Feb 2024   e-Newsletter Advertise | Editorial Calendar 
kpNext®
Latest e-Book
 
  Editorial Calendar
  Author Guidelines
Articles
  Artificial Intelligence in Oncology
A path to personalised cancer treatment
Nancy Kapila, Pharmaceutical Consultant
Cancer is the most prevalent cause of death across the globe. According to the World Health Organization, there is an estimated 77% increase from the anticipated 20 million cases of cancer in 2022. It is predicted that more than 35 million new cases of cancer will be diagnosed in 2050. The rapid rise in cancer has put the burden on the healthcare industry to bring innovation in the diagnosis and treatment methodologies to cure patients. One of the promising approaches to deal with growing cases of cancer is early detection for effective treatment and preventing...
Asia Healthcare Week
News
Immuneering's IMM-1-104 Receives...
Mabwell's Innovative B7-H3 ADC 7MW3711...
Techno Trends
 HKUMed Discovered Nanomedicine for Age-related Macular...
 Shorla Oncology Introduced Novel SH-105 for the Treatment of...
 University of Missouri Discovered Breakthrough Treatment for...
Press Releases
Hox Therapeutics and Vernalis Announce...
Matinas BioPharma Successfully Reaches...
Projects
 Full-Life Technologies Commences Construction on State-of-the-Art...
 BioNTech Invests US$150 million to Build mRNA Vaccine...
 Rentschler Biopharma to Open New Biopharma Manufacturing Facility...
Events
23 - 24 Feb 2024
MEPDPS 2024
29 - 01 Feb 2024
Biomarkers 2024
06 - 07 Mar 2024
25th Annual Clinical Trial Supply Europe 2024
Research Insights
  Effect of Antiplatelet Therapy After COVID-19 Diagnosis: A Systematic...
 A Computational Model to Characterize the Time-course of Response...
 Systems Approach for Congruence and Selection of Cancer Models...
Whitepapers
  The Reckoning of Antimicrobial Resistance, A new biological frontier
  Subscribe  |  e-book Archives  | Advisory Board  
Follow Us Facebook Twitter linkedin
www.pharmafocusasia.com - Owned by Ochre Media Pvt. Ltd.